7Baggers
Quarterly
Annual
    Unit: USD2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-07-31 2022-04-30 2022-01-31 
                     
      cash flows from operating activities:
    		                 
      net loss, including amounts attributable to noncontrolling interest
    		-3,513,000 -8,797,000 -9,996,000 -36,258,000 5,227,000 28,267,000 12,274,000 -54,887,000 -37,571,000 -286,355,000 -51,208,000 -52,899,000 -42,121,000 -50,465,000 -61,497,000 -26,613,000 -46,764,000 
      adjustments to reconcile net loss to net cash from operating activities:
    		                 
      stock-based compensation expense, net of amounts capitalized
    		53,158,000                 
      change in fair value of acquisition related contingent consideration
    		    0 0            
      charitable donation of common stock
    		1,597,000 1,970,000 1,787,000 1,739,000 2,956,000 2,957,000 2,957,000 2,957,000 2,675,000 2,675,000 2,675,000 2,675,000      
      amortization of intangible assets
    		2,015,000 2,015,000 2,015,000 2,020,000 2,195,000 2,511,000 2,333,000 1,087,000 521,000 521,000 546,000 579,000 595,000 591,000 595,000 581,000 414,000 
      depreciation and amortization
    		                 
      amortization of deferred contract acquisition costs
    		14,139,000 13,478,000 13,370,000 13,899,000 14,064,000 12,704,000 11,837,000 11,109,000 12,397,000 10,447,000 10,070,000 10,549,000 12,265,000 11,075,000 10,805,000 10,813,000 9,813,000 
      loss from equity method investment
    		        776,000 940,000 1,161,000 947,000 942,000 957,000 1,034,000 256,000  
      impairment of equity method investment
    		                 
      net amortization of premiums or discounts on short-term investments
    		-861,000 -1,741,000 -2,609,000 -2,996,000 -3,813,000 -3,792,000 -4,241,000 -4,900,000 -5,988,000 -5,867,000 -4,898,000 -3,596,000 -2,731,000 -2,053,000    
      unrealized foreign exchange loss
    		5,425,000 2,416,000 1,069,000 9,901,000 -4,084,000 -5,184,000 -803,000 545,000 4,396,000 -573,000   354,000 -2,509,000 -1,341,000 -231,000 637,000 
      other non-cash expense
    		367,000 231,000 192,000 208,000 162,000 467,000 -111,000 412,000 1,013,000 420,000   155,000 -30,000 737,000 -268,000 325,000 
      changes in assets and liabilities:
    		                 
      accounts receivable
    		-82,033,000 -23,472,000 3,859,000 65,928,000 -67,991,000 -32,883,000 -29,847,000 31,072,000 -31,050,000 -30,572,000 20,441,000 4,840,000 -32,006,000 -8,595,000 -22,242,000 8,674,000 -20,873,000 
      prepaid expenses and other current assets
    		-3,832,000 -7,036,000 1,219,000 1,527,000 5,926,000 -10,773,000 2,917,000 10,354,000 -15,671,000 -3,935,000 -2,161,000 -2,087,000 -3,589,000 168,000 -3,330,000 -2,158,000 -4,846,000 
      deferred contract acquisition costs
    		-22,966,000 -15,898,000 -12,304,000 -8,126,000 -22,421,000 -14,751,000 -12,415,000 -8,540,000 -21,340,000 -13,623,000 -9,640,000 -8,497,000 -15,410,000 -11,935,000    
      other non-current assets
    		395,000 233,000 -198,000 379,000 -1,034,000 1,348,000 -78,000 -419,000 865,000         
      accounts payable
    		794,000 -2,302,000 -472,000 3,586,000 5,472,000 -1,317,000 14,000 1,336,000 -3,219,000 799,000 1,135,000 -2,158,000 -1,106,000 865,000 -272,000 800,000 91,000 
      accrued expenses and other current liabilities
    		-624,000 6,140,000 -14,257,000 9,979,000 -11,665,000 -220,071,000 -41,250,000 19,617,000 12,436,000 244,674,000 -1,606,000 2,789,000 1,370,000 3,159,000 -1,479,000 1,569,000 12,934,000 
      accrued compensation and benefits
    		5,765,000 3,168,000 2,021,000 -13,084,000 13,558,000 -1,913,000 6,250,000 -13,152,000 12,331,000 231,000 7,732,000 -5,121,000 3,457,000 1,530,000 3,926,000 -20,606,000 15,943,000 
      deferred revenue
    		75,781,000 8,011,000 8,284,000 1,205,000 74,240,000 19,665,000 19,286,000 -4,448,000 50,189,000 17,983,000 2,792,000 8,383,000 32,803,000 22,651,000 10,862,000 6,687,000 37,605,000 
      other non-current liabilities
    		-946,000 461,000 346,000 12,000 3,295,000 -2,985,000 -10,889,000 2,806,000 -10,821,000 14,270,000        
      net cash from operating activities
    		45,757,000 31,428,000 49,369,000 106,302,000 63,222,000 -177,028,000 11,697,000 38,138,000 24,853,000 -5,961,000 27,109,000 -10,961,000 -11,720,000 -1,197,000 -36,335,000 -28,156,000 -1,094,000 
      capital expenditures
    		-3,973,000 0 -2,904,000 -912,000 -1,157,000 -1,057,000 -851,000 -700,000 -329,000 -736,000 -277,000 -256,000 -1,052,000 -1,784,000 -1,360,000 -1,874,000 0 
      free cash flows
    		41,784,000 31,428,000 46,465,000 105,390,000 62,065,000 -178,085,000 10,846,000 37,438,000 24,524,000 -6,697,000 26,832,000 -11,217,000 -12,772,000 -2,981,000 -37,695,000 -30,030,000 -1,094,000 
      cash flows from investing activities:
    		                 
      purchases of short-term investments
    		-213,209,000 -314,385,000 -237,946,000 -245,952,000 -204,304,000 -240,136,000 -118,866,000 -144,392,000 -242,021,000 -238,680,000 -276,132,000 -58,864,000 -189,671,000 -111,287,000 -473,303,000 -47,361,000 0 
      proceeds from maturities of short-term investments
    		164,139,000 241,641,000 184,280,000 163,606,000 183,520,000 148,763,000 121,412,000 254,687,000 207,028,000 253,995,000 189,484,000 83,500,000 108,925,000 72,670,000 0 50,031,000  
      proceeds from sales of short-term investments
    		0 0 0 1,367,000              
      additions to property and equipment
    		-3,973,000                 
      payments for business combination, net of cash acquired
    		    0 0 0 -20,210,000          
      payments for asset acquisition
    		    0 -346,000            
      escrow payment related to business combination, after acquisition date
    		        0 0        
      other investing activities
    		    0 0            
      net cash from investing activities
    		-53,043,000 -75,782,000 -56,570,000 -81,891,000 -21,941,000 -92,776,000 -5,162,000 89,385,000 -35,772,000 14,579,000 -89,425,000 24,380,000 -81,798,000 -40,401,000 -474,663,000 -8,824,000 46,136,000 
      cash flows from financing activities:
    		                 
      proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases
    		6,324,000 8,182,000 3,947,000 3,328,000 6,069,000 7,822,000 4,980,000 5,093,000 9,810,000 4,715,000 10,264,000 7,513,000 7,061,000 6,143,000 5,994,000 5,317,000 10,780,000 
      issuance of common stock under employee stock purchase plan
    		5,571,000 0   5,624,000 0   5,182,000 0   4,824,000 0    
      payments for taxes related to net share settlement of equity awards
    		-416,000                 
      settlement of acquisition related contingent cash consideration
    		    0             
      net cash from financing activities
    		11,479,000 7,653,000 12,351,000 3,328,000 11,693,000 2,922,000 12,912,000 5,093,000 14,992,000 4,715,000 18,015,000 7,513,000 11,885,000 7,059,000 34,815,000 43,723,000 9,597,000 
      impact of foreign exchange on cash and cash equivalents
    		1,152,000 -439,000 502,000 331,000 -1,957,000 4,898,000 -1,153,000 -290,000 -1,386,000 -1,249,000 -907,000 -401,000 4,866,000 -4,049,000 -549,000 -3,926,000  
      net increase in cash and cash equivalents
    		  5,652,000 28,070,000   18,294,000 132,326,000    20,531,000 -76,767,000   2,817,000  
      cash and cash equivalents at beginning of period
    		0 0 0 227,649,000 0 0            
      cash and cash equivalents at end of period
    		5,345,000 -37,140,000 5,652,000 255,719,000 51,017,000 -261,984,000            
      supplemental disclosure of cash flow information:
    		                 
      cash paid (refunds) for income taxes related to the bilateral advance pricing agreement
    		-28,000                 
      other cash paid for income taxes
    		3,608,000                 
      supplemental disclosure of non-cash investing and financing activities:
    		                 
      acquisition measurement period adjustment
    		                 
      vesting of early exercised stock options
    		   38,000    98,000    517,000    2,146,000  
      unpaid property and equipment in accounts payable and accrued expenses
    		-1,179,000 13,000                
      stock-based compensation capitalized as internal-use software cost
    		199,000                 
      depreciation expense
    		 869,000 759,000 556,000 499,000 680,000 744,000 937,000 1,039,000 1,123,000 1,114,000 1,092,000 1,033,000 912,000 728,000 558,000  
      net decrease in cash and cash equivalents
    		    51,017,000     12,084,000        
      stock-based compensation expense
    		  54,284,000 55,827,000 46,636,000 48,042,000 48,969,000 42,252,000 43,017,000 41,334,000 46,368,000 32,330,000 33,641,000 33,708,000 37,747,000 17,471,000 12,767,000 
      purchases of property and equipment
    		  -2,904,000 -912,000 -1,157,000 -1,057,000 -851,000 -700,000 -329,000 -736,000 -277,000 -256,000 -1,052,000 -1,784,000 -1,360,000 -1,874,000  
      cash paid (refunds) for income taxes
    		  -381,000 -1,295,000              
      unpaid direct transaction costs related to the asset acquisition in accrued expenses
    		                 
      unpaid property and equipment in accounts payable
    		   135,000              
      gain from deconsolidation of arch, formerly meltano
    		                 
      deconsolidation of arch, formerly meltano
    		                 
      contributions received from noncontrolling interests, net of issuance costs
    		            0 4,053,000 22,145,000 35,528,000  
      cash paid for income taxes related to the bilateral advance pricing agreement
    		    0             
      reconciliation of cash, cash equivalents and restricted cash within the consolidated balance sheets to the amounts shown in the statements of cash flows above:
    		                 
      cash and cash equivalents
    		                 
      restricted cash, included in prepaid expenses and other current assets
    		                 
      total cash, cash equivalents and restricted cash
    		                 
      cash paid for income taxes
    		      792,000 1,011,000 888,000 1,828,000 3,121,000 1,066,000 311,000 218,000 136,000 173,000  
      cash, cash equivalents, and restricted cash at beginning of period
    		       287,996,000 0 0 0 297,902,000 0 0 0 887,172,000  
      cash, cash equivalents, and restricted cash at end of period
    		       420,322,000 2,687,000 12,084,000 -45,208,000 318,433,000 -76,767,000 -38,588,000 -476,732,000 889,989,000  
      right-of-use assets obtained in exchange for new operating lease liabilities
    		       284,000          
      gain from the fair value change of acquisition related contingent consideration
    		                 
      payments for business combination, net of cash acquired and consideration withheld in an escrow
    		                 
      proceeds from initial public offering, net of underwriting discounts
    		                0 
      proceeds from warrants exercised
    		                 
      repurchase of common stock in a tender offer
    		                 
      partial settlement of acquisition related contingent cash consideration
    		            0     
      payments of deferred offering costs
    		                -1,269,000 
      cash donations
    		                 
      issuance of common stock upon conversion of preferred stock
    		                 
      unpaid property and equipment in accrued expenses
    		               33,000  
      unpaid deferred offering costs
    		                 
      restricted cash, included in other non-current assets
    		                 
      gain from deconsolidation of meltano inc.
    		            0 0 0 -17,798,000  
      deconsolidation of meltano inc.
    		            0 0 0 -9,620,000  
      other long-term assets
    		          -419,000 -302,000 962,000 -650,000 2,761,000 -61,000 -254,000 
      unrealized foreign exchange gain
    		           -262,000      
      other non-cash income
    		           -59,000      
      other long-term liabilities
    		           -164,000 -1,174,000 -576,000 -3,115,000 2,419,000 -1,496,000 
      proceeds from short-term borrowings from an investor in jihu
    		                 
      operating lease non-cash expense
    		                 
      payments for asset acquisitions
    		                 
      reconciliation of cash, cash equivalents and restricted cash within the consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above:
    		                 
      restricted cash, included in other long-term assets
    		                 
      costs deferred related to contract acquisition
    		               -10,249,000 -17,933,000 
      proceeds from short-term borrowings from a potential investor in jihu
    		               2,878,000  
      unpaid issuance costs related to capital contributions from noncontrolling interest holders
    		               744,000  
      net proceeds from series e preferred stock financing
    		                 
      contributions received from noncontrolling interests
    		                0 
      impact of foreign exchange on cash, cash equivalents and restricted cash
    		                 
      net increase in cash, cash equivalents and restricted cash
    		                 
      cash, cash equivalents and restricted cash at beginning of period
    		                 
      cash, cash equivalents and restricted cash at end of period
    		                 
      intangible assets acquisitions, net of cash acquired
    		                 
      repurchase of common stock
    		                 
      net increase in cash
    		                 
      cash and cash equivalents, beginning of period
    		                 
      cash and cash equivalents, end of period
    		                 
      conversion of convertible preferred stock to common stock upon initial public offering
    		                 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.